Horst MD2,3 & BP has following listings:
1) Risperdal 1mg Tablet Generic name: Risperidone 1mg Schedule: NSW: 4, QLD: 4, VIC: 4, SA : 4, WA : 4, TAS: 4, ACT: 4, NT : 4 PBS Listing: PBS/RPBS Authority required - 60 and 2 repeats Restrictions: Behavioural disturbances characterised by psychotic symptoms and aggression in patients with dementia where non-pharmacological methods have been unsuccessful ---------------------------------------------------------------- 2) Risperdal 1mg Tablet Generic name: Risperidone 1mg Schedule: NSW: 4, QLD: 4, VIC: 4, SA : 4, WA : 4, TAS: 4, ACT: 4, NT : 4 PBS Listing: PBS/RPBS Authority required - 60 and 5 repeats Restrictions: Adjunctive therapy to mood stabilisers for up to 6 months, of an episode of acute mania associated with bipolar I disorder Schizophrenia Now that is why I use BP. Safes me hours of having to log onto Government websites. Frank P does the work for me and for other Dr's. Note the quantity of 60 + 5 rpts vs. 60 & 2 Rpts as I explained earlier. Cedric ---------------------------------------------------------------------------- ------- -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of Horst Herb Sent: Thursday, 15 February 2007 3:22 PM To: General Practice Computing Group Talk Subject: Re: [GPCG_TALK] In quest of OS Medical Records for AU On Thursday 15 February 2007 15:07, Cedric Meyerowitz wrote: > Worldwide Risperdal got the indication for behaviour disturbance in > Dementia. Although Zyprexa often works well, they don't have the > indication. At one stage they promoted Zyprexa for Dementia with > aggression etc. They actually had to withdraw their promotional > material on this about 2 years ago. They don't have the data yet. > Risperdal does./ Firstly, there is no worldwide indication. There are "official" indications which manufactirersr have to apply for with the relevant authorities in each country - some countries may have mutual acceptance agreements in place, most don't. Manufactirers usually don't bother with the costly registration process in countries where they don't see a sufficient market Then there are "de facto" indications (so called "off label" prescriptions) - doctors having experienced a beneficial result of a drug for certain indications which may not be listed as official (eg Amitriptyline for chronic pain, AFAIK still not listed officially for that indication but nearly every pain clinic using it to that purpose) Both are entirely irrelevant for "PBS authority indication" which has been devised as a (sometimes foul) compromise between bureaucrats, health professionals and politicians; and since the PBS is a system unique to Oz (and something Oz can be proud of IMHO too!) anything that happns "worldwide" remains irrelevant to it Assuming the government keeps it's own web PBS listing up to date, what I can find on http://pbs.gov.au/html/healthpro/search/results?term=Risperdal&publication=G E suggests that Risperidone is not subsidized for the indication you mention And we are back to another typical Australian idiosyncrasy: disinformation, lack of information, artificial barriers to information, inefficient and unpredictable uinformation exchange. We are both professionals with comparable training and background and yet neither of us (or at least one of us, namely me) is utterly confused about how to legally prescribe either Risperidone or Olanzapine under PBS benefits. Horst _______________________________________________ Gpcg_talk mailing list [email protected] http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk _______________________________________________ Gpcg_talk mailing list [email protected] http://ozdocit.org/cgi-bin/mailman/listinfo/gpcg_talk
